var data={"title":"Adrenal steroid biosynthesis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Adrenal steroid biosynthesis</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/contributors\" class=\"contributor contributor_credentials\">Hershel Raff, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/contributors\" class=\"contributor contributor_credentials\">Lynnette K Nieman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/contributors\" class=\"contributor contributor_credentials\">Kathryn A Martin, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Oct 03, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The primary action of corticotropin (adrenocorticotropin; ACTH) on the adrenal cortex is to increase cortisol secretion by increasing its synthesis; intraadrenal cortisol storage is minimal [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/1\" class=\"abstract_t\">1</a>]. The major adrenal steroid hormones are synthesized in different areas of the adrenal cortex: glucocorticoids (particularly cortisol), androgens, and estrogens in the zona fasciculata and reticularis; and aldosterone in the zona glomerulosa. An appreciation of these pathways serves as the basis for understanding the different forms of congenital adrenal hyperplasia (CAH) and isolated hypoaldosteronism in which there are defects in the function of the enzymes involved in adrenal steroid hormone synthesis. It is also critical for understanding the mechanisms of action of new drugs directed at reducing cortisol synthesis in patients with Cushing's syndrome [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/2\" class=\"abstract_t\">2</a>]. (See <a href=\"topic.htm?path=medical-therapy-of-hypercortisolism-cushings-syndrome\" class=\"medical medical_review\">&quot;Medical therapy of hypercortisolism (Cushing's syndrome)&quot;</a>.)</p><p>The steps involved in the production of adrenal steroids will be reviewed here. The metabolism of adrenal steroids is reviewed in detail separately. (See <a href=\"topic.htm?path=metabolism-of-adrenal-steroids\" class=\"medical medical_review\">&quot;Metabolism of adrenal steroids&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">MECHANISM OF ACTH ACTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Corticotropin (ACTH) acts by binding to a specific cell-surface receptor, the melanocortin receptor-2 (MC2R) [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/3\" class=\"abstract_t\">3</a>]. ACTH upregulates expression of these receptors, thereby increasing the steroidogenic response to further ACTH stimulation [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/4\" class=\"abstract_t\">4</a>].</p><p>Failure of MC2R to activate in response to ACTH causes familial glucocorticoid deficiency (FGD), a rare autosomal recessive disorder characterized by severe cortisol deficiency with high plasma ACTH concentrations and normal mineralocorticoid levels. <em>MC2R </em>mutations resulting in effective loss of the receptor function are responsible for FGD type 1, which accounts for up to 25 percent of all FGD cases [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/5\" class=\"abstract_t\">5</a>]. (See <a href=\"topic.htm?path=causes-and-clinical-manifestations-of-primary-adrenal-insufficiency-in-children#H623801627\" class=\"medical medical_review\">&quot;Causes and clinical manifestations of primary adrenal insufficiency in children&quot;, section on 'Familial glucocorticoid deficiency (FGD)'</a>.)</p><p>The melanocortin receptor accessory protein (MRAP) and its paralogue MRAP2 are small, single-pass transmembrane proteins; MRAP is a key accessory factor for the functional expression of the <span class=\"nowrap\">MC2R/ACTH</span> receptor. The clinical observation that 20 percent of FGD cases are due to inactivating <em>MRAP</em> mutations highlights the importance of MRAP in adrenal gland physiology [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/6\" class=\"abstract_t\">6</a>].</p><p>ACTH binding to its receptors activates adenylyl cyclase, increasing cyclic AMP (cAMP) production, which in turn stimulates cAMP-dependent protein kinase (protein kinase A) and phosphorylation of a number of proteins.</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">CHOLESTEROL SUBSTRATE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cholesterol is the substrate for the synthesis of all steroid hormones. Steroidogenesis requires coordinated regulation of the cellular uptake, transport, and utilization of cholesterol followed by a series of unique biosynthetic steps. These processes are coordinated by the sterol regulatory element binding proteins (SREBPs), a family of basic helix-loop-helix transcriptional regulators that are also involved in lipid metabolism and adipocyte differentiation [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/7\" class=\"abstract_t\">7</a>]. The cells of the adrenal cortex can either take up cholesterol from the circulation or synthesize cholesterol de novo from acetate. In humans, cholesterol for adrenal steroidogenesis is taken up from the bloodstream as:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Serum low-density lipoproteins (LDL) [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/8-10\" class=\"abstract_t\">8-10</a>], which are delivered to the interior of adrenocortical cells via specific cell-surface receptors for LDL [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/11,12\" class=\"abstract_t\">11,12</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>High-density lipoprotein (HDL) cholesterol can be a source of substrate for human adrenal steroidogenesis. In patients in whom delivery of LDL cholesterol to the adrenal is impaired, basal adrenal steroidogenesis is normal. Patients with abetalipoproteinemia, a heritable deficiency of apolipoprotein B production and no LDL in serum, and patients with familial hypercholesterolemia caused by defects in the LDL receptor system have normal basal cortisol production [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/13,14\" class=\"abstract_t\">13,14</a>].</p><p/><p class=\"bulletIndent1\">A receptor system for HDL, SR-B1 (scavenger receptor, class B, type 1), transfers HDL cholesterol into cells without endocytosis of the entire lipoprotein particle, as occurs with LDL [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/15\" class=\"abstract_t\">15</a>]. SR-B1-knockout mice have lipid-depleted adrenocortical cells and high serum HDL cholesterol concentrations [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/16\" class=\"abstract_t\">16</a>]. The human homolog of SR-B1, called CLA-1, is expressed in liver and steroidogenic cells and transfers HDL cholesterol into cultured adrenal cells [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/17,18\" class=\"abstract_t\">17,18</a>]. In contrast to rodents, HDL and CLA-1 play a minor role in human steroidogenesis.</p><p/><p class=\"bulletIndent1\">Expression of SR-B1 is regulated as follows:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>It is stimulated or positively regulated by activation of adenylyl cyclase, the transcription factor steroidogenic factor-1 (SF-1), sterol regulatory element-binding protein 1a (SREBP-1a), and cofactors such as promoter-specific transcription factor (Sp1). Patients heterozygous for inactivating SF-1 mutations have adrenal insufficiency [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/19\" class=\"abstract_t\">19</a>].</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>It is suppressed by the intracellular level of cholesterol and negatively regulated by the dose-sensitive sex reversal-adrenal hypoplasia gene on the X chromosome, gene 1 (DAX-1) transcription factor [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/20,21\" class=\"abstract_t\">20,21</a>]. <span class=\"nowrap\">Dax-1(-/Y)</span> mice have normal basal serum corticosterone levels and have greater corticosterone responses to ACTH than wild-type mice [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/22\" class=\"abstract_t\">22</a>].</p><p/><p>Free cholesterol is generated from LDL sources of cholesteryl esters by lysosomal acid lipase (LAL). Mutations in LAL (encoded by the <em>LIPA</em> gene) cause lysosomal acid lipase deficiency (Wolman <span class=\"nowrap\">disease/cholesteryl</span> ester storage disease). (See <a href=\"topic.htm?path=inborn-errors-of-metabolism-epidemiology-pathogenesis-and-clinical-features\" class=\"medical medical_review\">&quot;Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">CORTISOL BIOSYNTHESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Four distinct cytochrome P450 enzymes are involved in adrenal corticosteroid biosynthesis. They are members of a large family of cytochrome P450 oxidative enzymes, so named because they have a characteristic 450 nm absorbance maximum when reduced with carbon monoxide. These enzymes serve a variety of biologic functions [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/23\" class=\"abstract_t\">23</a>]. They transfer electrons from NADPH, provided by an electron-transport protein intermediary, to molecular oxygen with concomitant oxygenation of a number of substrates. The nomenclature of these enzymes has been changed as a result of insights gained from molecular cloning. The current terminology based on the name of the gene, previous designation based on the P450 structure and function, and common functional names are shown in the table (<a href=\"image.htm?imageKey=ENDO%2F55287\" class=\"graphic graphic_table graphicRef55287 \">table 1</a>).</p><p>The substrates for the steroidogenic P450 enzymes are carbon atoms of the four-ring structures of cholesterol (<a href=\"image.htm?imageKey=ENDO%2F71558\" class=\"graphic graphic_figure graphicRef71558 \">figure 1</a>) [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/23\" class=\"abstract_t\">23</a>].</p><p>Each enzymatic step in cortisol biosynthesis is compartmentalized within the cell by virtue of the subcellular localization of the enzyme involved.</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Pregnenolone synthesis by CYP11A1</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The rate-limiting process in steroidogenesis is the transport of free cholesterol through the cytosol to the inner mitochondrial membrane, the site of the cholesterol side-chain cleavage enzyme (CYP11A1) that catalyzes the first step in steroidogenesis (<a href=\"image.htm?imageKey=ENDO%2F71558\" class=\"graphic graphic_figure graphicRef71558 \">figure 1</a>).</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cholesterol transport into mitochondria is mediated by a protein designated StAR (steroidogenic acute regulatory protein) [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/24-26\" class=\"abstract_t\">24-26</a>]; in the absence of this protein, steroidogenesis is severely impaired [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/24\" class=\"abstract_t\">24</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basal and cAMP-stimulated StAR<em> </em>expression are increased by steroidogenic factor-1 (SF-1) acting in concert with promotor-specific transcription factor (Sp1) [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/27\" class=\"abstract_t\">27</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Another multimeric protein complex, the translocator protein (TSPO, 18-kDa) formerly known as the peripheral benzodiazepine receptor (PBR), is also involved in the transfer of cholesterol into the mitochondrion [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/28,29\" class=\"abstract_t\">28,29</a>]. Therefore, TSPO may be necessary for corticotropin (ACTH)-mediated steroidogenesis [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/30\" class=\"abstract_t\">30</a>].</p><p/><p>Within mitochondria, pregnenolone is derived from cholesterol by removal of the side-chain at C20 catalyzed by a single enzyme derived from the <em>CYP11A1</em> gene [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/31\" class=\"abstract_t\">31</a>].</p><p>The electrons transferred by CYP11A1<em> </em>during the side-chain cleavage reaction are provided through an electron transport system comprised of adrenodoxin, which exists in a soluble form in mitochondria, and adrenodoxin reductase, a mitochondrial membrane-bound flavoprotein. Adrenodoxin reductase accepts electrons from an NADPH-dependent cytochrome P450 reductase and transfers them to adrenodoxin, which serves as a shuttle to deliver reducing equivalents to various P450 enzymes [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/32,33\" class=\"abstract_t\">32,33</a>].</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Conversion of pregnenolone to progesterone</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Newly synthesized pregnenolone is converted to progesterone by dehydrogenation of the 3-hydroxyl group of pregnenolone and isomerization of the double bond at C5 (<a href=\"image.htm?imageKey=ENDO%2F71558\" class=\"graphic graphic_figure graphicRef71558 \">figure 1</a>). These reactions are catalyzed by HSD3B2 (3-beta-hydroxysteroid dehydrogenase 2), a microsomal (endoplasmic reticulum) membrane-associated enzyme that is expressed only in the adrenals and gonads [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/34\" class=\"abstract_t\">34</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Progesterone to 17-alpha-hydroxyprogesterone</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>CYP17<em> </em>is a microsomal enzyme that catalyzes both hydroxylation at C17 of progesterone or pregnenolone (17-alpha-hydroxylase activity) and cleavage of the residual 2-carbon side-chain at C17 (17,20-lyase activity) [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/35\" class=\"abstract_t\">35</a>].</p><p>The dual function of CYP17 allows steroidogenesis to be directed to several different pathways:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>17-alpha-hydroxylated substrates with the side-chain intact are glucocorticoid precursors</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Generation of C19 steroids by both 17-alpha-hydroxylase and 17,20-lyase activities directs substrate towards androgen and estrogen synthesis (<a href=\"image.htm?imageKey=ENDO%2F71558\" class=\"graphic graphic_figure graphicRef71558 \">figure 1</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In the zona glomerulosa, which lacks either form of CYP17 activity, pregnenolone is converted into aldosterone</p><p/><p>Whether a steroid molecule undergoes both 17-alpha-hydroxylation and lysis of the 17,20 bond appears to depend upon the availability of electrons from a flavoprotein distinct from mitochondrial adrenodoxin. This protein also supplies electrons to CYP21A1, the other microsomal P450 enzyme [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/36\" class=\"abstract_t\">36</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">17-alpha-hydroxyprogesterone to 11-deoxycortisol</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Both progesterone and 17-alpha-hydroxyprogesterone are 21-hydroxylated by a single CYP21A2 enzyme (21-hydroxylase) located in the smooth endoplasmic reticulum [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/36\" class=\"abstract_t\">36</a>]. There are two related <em>CYP21</em> genes on chromosome 6p21.3 [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/37\" class=\"abstract_t\">37</a>], but only one is active [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/38\" class=\"abstract_t\">38</a>].</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Conversion of 11-deoxycortisol to cortisol</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The last step in cortisol biosynthesis is the 11-beta-hydroxylation of 11-deoxycortisol, a reaction catalyzed by the mitochondrial enzyme CYP11B1. Like CYP11A1, the other P450 enzyme of the inner mitochondrial membrane, CYP11B1 receives electrons from NADPH via adrenodoxin reductase and adrenodoxin [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/39\" class=\"abstract_t\">39</a>].</p><p>CYP11B1 is nearly identical to the CYP11B2 enzyme responsible for the terminal steps of aldosterone synthesis, except that it lacks the ability to convert corticosterone to aldosterone. CYP11B1 is more closely related to CYP11A1 than to the microsomal P450 enzymes [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/40,41\" class=\"abstract_t\">40,41</a>]. CYP11B1 expression is increased by cyclic AMP (cAMP) and SF-1 [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/42\" class=\"abstract_t\">42</a>].</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h1\">ALDOSTERONE BIOSYNTHESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Progesterone is also the substrate for mineralocorticoid synthesis. In the zona glomerulosa, progesterone is hydroxylated at C21 by CYP21A2 to yield deoxycorticosterone. All three terminal steps in the conversion of this intermediate to aldosterone (11-beta-hydroxylation, 18-hydroxylation, and 18-methyl oxidation) are catalyzed by a single mitochondrial P450 enzyme, CYP11B2 (aldosterone synthase, P450c11as) [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/43,44\" class=\"abstract_t\">43,44</a>]. The human CYP11B2 is encoded by a gene closely related to CYP11B1 (11-beta-hydroxylase), with over 90 percent homology at the protein level. The <em>CYP11B2</em> gene is also located on chromosome 8q24.3, near the <em>CYP11B1</em> gene [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/45\" class=\"abstract_t\">45</a>]. (See <a href=\"topic.htm?path=familial-hyperaldosteronism\" class=\"medical medical_review\">&quot;Familial hyperaldosteronism&quot;</a>.)</p><p>The zona glomerulosa is well adapted for the production of aldosterone.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>It has a low concentration of CYP17 (17-hydroxylase), the enzyme that directs substrate along the pathways to cortisol and androgen synthesis.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>It is the only adrenocortical zone that has the enzyme required for the sequential conversion of deoxycorticosterone to aldosterone [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/44\" class=\"abstract_t\">44</a>].</p><p/><p>The restriction of <em>CYP11B2</em> (aldosterone synthase) expression to the zona glomerulosa is very important physiologically. Expression of the gene in the zona fasciculata would render aldosterone production subject to regulation by corticotropin (ACTH). Such a complication occurs in patients with glucocorticoid-remediable aldosteronism. (See <a href=\"topic.htm?path=familial-hyperaldosteronism\" class=\"medical medical_review\">&quot;Familial hyperaldosteronism&quot;</a>.)</p><p>In normal subjects, angiotensin II and a small rise in the serum potassium concentration are the primary stimuli to aldosterone release. Steroidogenic factor-1 (SF-1), which stimulates <em>CYP11B1</em> gene expression, does not alter the expression of the <em>CYP11B2</em> gene [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/42\" class=\"abstract_t\">42</a>]. Expression of steroidogenic acute regulatory protein (StAR), which increases aldosterone synthesis, is stimulated by increased intracellular calcium concentration [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/28\" class=\"abstract_t\">28</a>].</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h1\">ADRENAL ANDROGEN BIOSYNTHESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Steroids with 19 carbon atoms and androgenic activity are synthesized by the adrenals. In fact, dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS) are the most abundant products of the adrenal glands. They are formed in the zona reticularis, which has no 3-beta-hydroxysteroid dehydrogenase 2 (HSD3B2) [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/46\" class=\"abstract_t\">46</a>], from 17-alpha-hydroxypregnenolone by the 17,20-lyase activity of CYP17<em> </em>(<a href=\"image.htm?imageKey=ENDO%2F71558\" class=\"graphic graphic_figure graphicRef71558 \">figure 1</a>).</p><p>Androstenedione, another weak androgen, is produced by side-chain cleavage of 17-alpha-hydroxyprogesterone by CYP17 and is subsequently converted to testosterone by HSD17B3 (17-ketosteroid reductase), mainly in peripheral tissues. There is minimal synthesis of testosterone in the adrenal gland. (See <a href=\"topic.htm?path=adrenal-hyperandrogenism\" class=\"medical medical_review\">&quot;Adrenal hyperandrogenism&quot;</a>.)</p><p>In addition to corticotropin (ACTH), several factors have been proposed as stimuli of adrenal androgen secretion [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/47,48\" class=\"abstract_t\">47,48</a>]. One proposed factor is prolactin as there are prolactin receptors expressed by adrenocortical cells. In women with prolactinomas, serum DHEAS concentrations are weakly correlated with serum prolactin concentrations.</p><p>Adrenal androgen secretion is reduced in patients receiving T lymphocyte-suppressive drugs [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/49\" class=\"abstract_t\">49</a>]. T lymphocytes are present in the zona reticularis and form direct cell-cell contact with zona reticularis steroidogenic cells, which constitutively express major histocompatibility complex (MHC) class II molecules [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/50\" class=\"abstract_t\">50</a>]. Lymphocytes increase DHEA secretion by adrenal cells fourfold in vitro, an effect greater than that of maximally stimulating ACTH concentrations [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/49\" class=\"abstract_t\">49</a>].</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h1\">ACUTE AND CHRONIC ACTIONS OF ACTH</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The effects of corticotropin (ACTH) on steroidogenesis can be divided into acute effects, which occur within minutes, and chronic effects, which occur in hours or days [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/51\" class=\"abstract_t\">51</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The acute effect of ACTH is to increase cholesterol transfer from the cytoplasm to the inner mitochondrial membrane so that it can be converted to delta-5-pregnenolone by CYP11A1. This is the initial and rate-limiting step in cortisol biosynthesis (<a href=\"image.htm?imageKey=ENDO%2F71558\" class=\"graphic graphic_figure graphicRef71558 \">figure 1</a>) [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/51\" class=\"abstract_t\">51</a>]. Increases in cholesterol transport depend on the ACTH-stimulated increase in cyclic (cAMP) generation and phosphorylation of steroidogenic acute regulatory protein (StAR) [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/26,52-54\" class=\"abstract_t\">26,52-54</a>]. The chronic effects of ACTH involve increased synthesis of most of the enzymes of the steroidogenic pathway and more general actions on adrenocortical cell protein, RNA and DNA synthesis, and cell growth [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/23\" class=\"abstract_t\">23</a>]. In bovine adrenocortical cells, ACTH increases the rate of synthesis of all steroidogenic CYP enzymes, including CYP11A1, CYP17, CYP21A2, and CYP11B1 [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/55\" class=\"abstract_t\">55</a>], plus the electron-transport protein adrenodoxin [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/56\" class=\"abstract_t\">56</a>] and adrenodoxin reductase [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/51\" class=\"abstract_t\">51</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>ACTH also increases the synthesis of other proteins required for steroidogenesis. These include the low-density lipoprotein (LDL) and high-density lipoprotein (HDL) receptors [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/57\" class=\"abstract_t\">57</a>], adrenodoxin [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/57\" class=\"abstract_t\">57</a>], and sterol-carrier protein (SCP2) [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/58\" class=\"abstract_t\">58</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>ACTH action on glomerulosa cells is complex. It initially stimulates and later suppresses aldosterone synthase gene expression. For this reason, exogenous ACTH stimulation can be used to assess zona glomerulosa function [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/59,60\" class=\"abstract_t\">59,60</a>] and is useful during adrenal vein catheterization in the differential diagnosis of hyperaldosteronism [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/61\" class=\"abstract_t\">61</a>]. (See <a href=\"topic.htm?path=diagnosis-of-primary-aldosteronism#H20\" class=\"medical medical_review\">&quot;Diagnosis of primary aldosteronism&quot;, section on 'Adrenal vein sampling'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H239059580\"><span class=\"h1\">METABOLISM OF ADRENAL STEROIDS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The peripheral and target tissue metabolism of adrenal steroids is reviewed in detail separately. (See <a href=\"topic.htm?path=metabolism-of-adrenal-steroids\" class=\"medical medical_review\">&quot;Metabolism of adrenal steroids&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h1\">OVERVIEW OF CAH</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Inherited defects in the enzymatic steps of cortisol biosynthesis result in a group of syndromes termed congenital adrenal hyperplasia (CAH) (<a href=\"image.htm?imageKey=ENDO%2F71558\" class=\"graphic graphic_figure graphicRef71558 \">figure 1</a>). These disorders are all inherited as autosomal recessive traits [<a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/28\" class=\"abstract_t\">28</a>]. (See <a href=\"topic.htm?path=diagnosis-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency-in-infants-and-children\" class=\"medical medical_review\">&quot;Diagnosis of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in infants and children&quot;</a> and <a href=\"topic.htm?path=genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency\" class=\"medical medical_review\">&quot;Genetics and clinical presentation of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency&quot;</a>.)</p><p>The resulting decrease in cortisol production causes an increase in the secretion of corticotropin (ACTH), thereby stimulating the production of adrenal steroids up to and including the substrate for the defective enzyme. The clinical manifestations reflect one or more of the following:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Impaired synthesis of cortisol.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In some cases, impaired synthesis of aldosterone.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Excessive synthesis of precursor steroids due to the increase in ACTH secretion. This can result in increases in adrenal androgenic hormones (which can cause virilization) and in deoxycorticosterone (which has mineralocorticoid activity and can cause hypertension).</p><p/><p>What follows is a brief review of the consequences of the different enzymatic defects, each of which is discussed in detail elsewhere (<a href=\"image.htm?imageKey=ENDO%2F76865\" class=\"graphic graphic_table graphicRef76865 \">table 2</a>).</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Salt wasting and hyperkalemia, resulting from mineralocorticoid deficiency, occur in <em>CYP21A2</em> deficiency, <em>HSD3B2</em> deficiency, and congenital lipoid adrenal hyperplasia. (See <a href=\"topic.htm?path=genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency\" class=\"medical medical_review\">&quot;Genetics and clinical presentation of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency&quot;</a> and <a href=\"topic.htm?path=uncommon-congenital-adrenal-hyperplasias#H2642991429\" class=\"medical medical_review\">&quot;Uncommon congenital adrenal hyperplasias&quot;, section on 'Lipoid congenital adrenal hyperplasia'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Similar abnormalities occur as the sole finding with defects in aldosterone synthase; cortisol synthesis is intact in these disorders. (See <a href=\"topic.htm?path=etiology-diagnosis-and-treatment-of-hypoaldosteronism-type-4-rta\" class=\"medical medical_review\">&quot;Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypertension and frequently hypokalemia due to excess deoxycorticosterone is the major abnormality in <em>CYP17</em> (17-alpha-hydroxylase) and <em>CYP11B1</em> deficiencies. (See <a href=\"topic.htm?path=uncommon-congenital-adrenal-hyperplasias#H93046139\" class=\"medical medical_review\">&quot;Uncommon congenital adrenal hyperplasias&quot;, section on '11-beta-hydroxylase deficiency'</a> and <a href=\"topic.htm?path=uncommon-congenital-adrenal-hyperplasias#H2642991429\" class=\"medical medical_review\">&quot;Uncommon congenital adrenal hyperplasias&quot;, section on 'Lipoid congenital adrenal hyperplasia'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Virilization of female fetuses or hirsutism and virilization of females later in life occurs in <em>CYP21A2</em> (21-hydroxylase) deficiency and in <em>CYP11B1</em> (11-beta-hydroxylase) deficiency because of increased androgen synthesis. (See <a href=\"topic.htm?path=genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency\" class=\"medical medical_review\">&quot;Genetics and clinical presentation of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency&quot;</a> and <a href=\"topic.htm?path=uncommon-congenital-adrenal-hyperplasias#H93046139\" class=\"medical medical_review\">&quot;Uncommon congenital adrenal hyperplasias&quot;, section on '11-beta-hydroxylase deficiency'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypogonadism and disorders of sex development can be a consequence of <em>CYP17</em> deficiency, <em>HSD3B2</em> deficiency, or congenital lipoid adrenal hyperplasia. (See <a href=\"topic.htm?path=uncommon-congenital-adrenal-hyperplasias#H2642991429\" class=\"medical medical_review\">&quot;Uncommon congenital adrenal hyperplasias&quot;, section on 'Lipoid congenital adrenal hyperplasia'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H239059600\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The primary action of corticotropin (ACTH) on the adrenal cortex is to increase cortisol secretion by increasing its synthesis; intraadrenal cortisol storage is minimal. The major adrenal steroid hormones are synthesized in different areas of the adrenal cortex:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Glucocorticoids (particularly cortisol), androgens, and estrogens in the zona fasciculata and reticularis</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Aldosterone in the zona glomerulosa</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cholesterol is the substrate for the synthesis of all steroid hormones. The cells of the adrenal cortex can either take up cholesterol from the circulation or synthesize cholesterol de novo from acetate. (See <a href=\"#H3\" class=\"local\">'Cholesterol substrate'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Four distinct cytochrome P450 enzymes are involved in adrenal corticosteroid biosynthesis (<a href=\"image.htm?imageKey=ENDO%2F55287\" class=\"graphic graphic_table graphicRef55287 \">table 1</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The steps of cortisol biosynthesis are shown in the figure (<a href=\"image.htm?imageKey=ENDO%2F71558\" class=\"graphic graphic_figure graphicRef71558 \">figure 1</a>). (See <a href=\"#H4\" class=\"local\">'Cortisol biosynthesis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The steps of aldosterone and adrenal androgen biosynthesis are reviewed above (<a href=\"image.htm?imageKey=ENDO%2F71558\" class=\"graphic graphic_figure graphicRef71558 \">figure 1</a>). (See <a href=\"#H10\" class=\"local\">'Aldosterone biosynthesis'</a> above and <a href=\"#H11\" class=\"local\">'Adrenal androgen biosynthesis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Inherited defects in the enzymatic steps of cortisol biosynthesis result in a group of syndromes termed congenital adrenal hyperplasia (CAH) (<a href=\"image.htm?imageKey=ENDO%2F71558\" class=\"graphic graphic_figure graphicRef71558 \">figure 1</a>). These disorders are all inherited as autosomal recessive traits. An overview of the different forms of CAH is found above. (See <a href=\"#H13\" class=\"local\">'Overview of CAH'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/1\" class=\"nounderline abstract_t\">Dickerman Z, Grant DR, Faiman C, Winter JS. Intraadrenal steroid concentrations in man: zonal differences and developmental changes. J Clin Endocrinol Metab 1984; 59:1031.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/2\" class=\"nounderline abstract_t\">Fleseriu M. Medical treatment of Cushing disease: new targets, new hope. Endocrinol Metab Clin North Am 2015; 44:51.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/3\" class=\"nounderline abstract_t\">Cone RD, Mountjoy KG. Molecular genetics of the ACTH and melanocyte-stimulating hormone receptors. Trends Endocrinol Metab 1993; 4:242.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/4\" class=\"nounderline abstract_t\">Penhoat A, Lebrethon MC, B&eacute;geot M, Saez JM. Regulation of ACTH receptor mRNA and binding sites by ACTH and angiotensin II in cultured human and bovine adrenal fasciculata cells. Endocr Res 1995; 21:157.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/5\" class=\"nounderline abstract_t\">Clark AJ, Metherell LA, Cheetham ME, Huebner A. Inherited ACTH insensitivity illuminates the mechanisms of ACTH action. Trends Endocrinol Metab 2005; 16:451.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/6\" class=\"nounderline abstract_t\">Novoselova TV, Jackson D, Campbell DC, et al. Melanocortin receptor accessory proteins in adrenal gland physiology and beyond. J Endocrinol 2013; 217:R1.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/7\" class=\"nounderline abstract_t\">Jeon TI, Osborne TF. SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab 2012; 23:65.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/8\" class=\"nounderline abstract_t\">Borkowski AJ, Levin S, Delcroix C, et al. Blood cholesterol and hydrocortisone production in man: quantitative aspects of the utilization of circulating cholesterol by the adrenals at rest and under adrenocorticotropin stimulation. J Clin Invest 1967; 46:797.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/9\" class=\"nounderline abstract_t\">Bolt&eacute; E, Coudert S, Lefebvre Y. Steroid production from plasma cholesterol. II. In vivo conversion of plasma cholesterol to ovarian progesterone and adrenal C19 and C21 steroids in humans. J Clin Endocrinol Metab 1974; 38:394.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/10\" class=\"nounderline abstract_t\">Gwynne JT, Strauss JF 3rd. The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands. Endocr Rev 1982; 3:299.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/11\" class=\"nounderline abstract_t\">Faust JR, Goldstein JL, Brown MS. Receptor-mediated uptake of low density lipoprotein and utilization of its cholesterol for steroid synthesis in cultured mouse adrenal cells. J Biol Chem 1977; 252:4861.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/12\" class=\"nounderline abstract_t\">Goldstein JL, Anderson RG, Brown MS. Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature 1979; 279:679.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/13\" class=\"nounderline abstract_t\">Illingworth DR, Kenny TA, Orwoll ES. Adrenal function in heterozygous and homozygous hypobetalipoproteinemia. J Clin Endocrinol Metab 1982; 54:27.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/14\" class=\"nounderline abstract_t\">Illingworth DR, Lees AM, Lees RS. Adrenal cortical function in homozygous familial hypercholesterolemia. Metabolism 1983; 32:1045.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/15\" class=\"nounderline abstract_t\">Acton S, Rigotti A, Landschulz KT, et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996; 271:518.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/16\" class=\"nounderline abstract_t\">Rigotti A, Trigatti BL, Penman M, et al. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci U S A 1997; 94:12610.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/17\" class=\"nounderline abstract_t\">Imachi H, Murao K, Sato M, et al. CD36 LIMPII analogous-1, a human homolog of the rodent scavenger receptor B1, provides the cholesterol ester for steroidogenesis in adrenocortical cells. Metabolism 1999; 48:627.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/18\" class=\"nounderline abstract_t\">Murao K, Terpstra V, Green SR, et al. Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J Biol Chem 1997; 272:17551.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/19\" class=\"nounderline abstract_t\">Biason-Lauber A, Schoenle EJ. Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. Am J Hum Genet 2000; 67:1563.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/20\" class=\"nounderline abstract_t\">Cao G, Zhao L, Stangl H, et al. Developmental and hormonal regulation of murine scavenger receptor, class B, type 1. Mol Endocrinol 1999; 13:1460.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/21\" class=\"nounderline abstract_t\">Lopez D, Shea-Eaton W, Sanchez MD, McLean MP. DAX-1 represses the high-density lipoprotein receptor through interaction with positive regulators sterol regulatory element-binding protein-1a and steroidogenic factor-1. Endocrinology 2001; 142:5097.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/22\" class=\"nounderline abstract_t\">Babu PS, Bavers DL, Beuschlein F, et al. Interaction between Dax-1 and steroidogenic factor-1 in vivo: increased adrenal responsiveness to ACTH in the absence of Dax-1. Endocrinology 2002; 143:665.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/23\" class=\"nounderline abstract_t\">Miller WL. Molecular biology of steroid hormone synthesis. Endocr Rev 1988; 9:295.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/24\" class=\"nounderline abstract_t\">Lin D, Sugawara T, Strauss JF 3rd, et al. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 1995; 267:1828.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/25\" class=\"nounderline abstract_t\">Waterman MR. A rising StAR: an essential role in cholesterol transport. Science 1995; 267:1780.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/26\" class=\"nounderline abstract_t\">Stocco DM, Clark BJ. Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev 1996; 17:221.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/27\" class=\"nounderline abstract_t\">Sugawara T, Saito M, Fujimoto S. Sp1 and SF-1 interact and cooperate in the regulation of human steroidogenic acute regulatory protein gene expression. Endocrinology 2000; 141:2895.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/28\" class=\"nounderline abstract_t\">White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000; 21:245.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/29\" class=\"nounderline abstract_t\">Papadopoulos V, Baraldi M, Guilarte TR, et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 2006; 27:402.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/30\" class=\"nounderline abstract_t\">Fan J, Campioli E, Midzak A, et al. Conditional steroidogenic cell-targeted deletion of TSPO unveils a crucial role in viability and hormone-dependent steroid formation. Proc Natl Acad Sci U S A 2015; 112:7261.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/31\" class=\"nounderline abstract_t\">Chung BC, Matteson KJ, Voutilainen R, et al. Human cholesterol side-chain cleavage enzyme, P450scc: cDNA cloning, assignment of the gene to chromosome 15, and expression in the placenta. Proc Natl Acad Sci U S A 1986; 83:8962.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/32\" class=\"nounderline abstract_t\">Kimura T, Suzuki K. Components of the electron transport system in adrenal steroid hydroxylase. Isolation and properties of non-heme iron protein (adrenodoxin). J Biol Chem 1967; 242:485.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/33\" class=\"nounderline abstract_t\">Kominami S, Hara H, Ogishima T, Takemori S. Interaction between cytochrome P-450 (P-450C21) and NADPH-cytochrome P-450 reductase from adrenocortical microsomes in a reconstituted system. J Biol Chem 1984; 259:2991.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/34\" class=\"nounderline abstract_t\">Penning TM. Molecular endocrinology of hydroxysteroid dehydrogenases. Endocr Rev 1997; 18:281.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/35\" class=\"nounderline abstract_t\">Yanase T, Simpson ER, Waterman MR. 17 alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr Rev 1991; 12:91.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/36\" class=\"nounderline abstract_t\">Kominami S, Ochi H, Kobayashi Y, Takemori S. Studies on the steroid hydroxylation system in adrenal cortex microsomes. Purification and characterization of cytochrome P-450 specific for steroid C-21 hydroxylation. J Biol Chem 1980; 255:3386.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/37\" class=\"nounderline abstract_t\">White PC, Chaplin DD, Weis JH, et al. Two steroid 21-hydroxylase genes are located in the murine S region. Nature 1984; 312:465.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/38\" class=\"nounderline abstract_t\">White PC, New MI, Dupont B. HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation. Proc Natl Acad Sci U S A 1984; 81:7505.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/39\" class=\"nounderline abstract_t\">Chu JW, Kimura T. Studies on adrenal steroid hydroxylases. Molecular and catalytic properties of adrenodoxin reductase (a flavoprotein). J Biol Chem 1973; 248:2089.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/40\" class=\"nounderline abstract_t\">Chua SC, Szabo P, Vitek A, et al. Cloning of cDNA encoding steroid 11 beta-hydroxylase (P450c11). Proc Natl Acad Sci U S A 1987; 84:7193.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/41\" class=\"nounderline abstract_t\">John ME, John MC, Simpson ER, Waterman MR. Regulation of cytochrome P-45011 beta gene expression by adrenocorticotropin. J Biol Chem 1985; 260:5760.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/42\" class=\"nounderline abstract_t\">Wang XL, Bassett M, Zhang Y, et al. Transcriptional regulation of human 11beta-hydroxylase (hCYP11B1). Endocrinology 2000; 141:3587.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/43\" class=\"nounderline abstract_t\">White PC, Curnow KM, Pascoe L. Disorders of steroid 11 beta-hydroxylase isozymes. Endocr Rev 1994; 15:421.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/44\" class=\"nounderline abstract_t\">White PC. Disorders of aldosterone biosynthesis and action. N Engl J Med 1994; 331:250.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/45\" class=\"nounderline abstract_t\">Taymans SE, Pack S, Pak E, et al. Human CYP11B2 (aldosterone synthase) maps to chromosome 8q24.3. J Clin Endocrinol Metab 1998; 83:1033.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/46\" class=\"nounderline abstract_t\">Endoh A, Kristiansen SB, Casson PR, et al. The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3 beta-hydroxysteroid dehydrogenase. J Clin Endocrinol Metab 1996; 81:3558.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/47\" class=\"nounderline abstract_t\">Ib&aacute;&ntilde;ez L, Dimartino-Nardi J, Potau N, Saenger P. Premature adrenarche--normal variant or forerunner of adult disease? Endocr Rev 2000; 21:671.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/48\" class=\"nounderline abstract_t\">Bertagna X. Effects of Chronic ACTH Excess on Human Adrenal Cortex. Front Endocrinol (Lausanne) 2017; 8:43.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/49\" class=\"nounderline abstract_t\">Wolkersd&ouml;rfer GW, Lohmann T, Marx C, et al. Lymphocytes stimulate dehydroepiandrosterone production through direct cellular contact with adrenal zona reticularis cells: a novel mechanism of immune-endocrine interaction. J Clin Endocrinol Metab 1999; 84:4220.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/50\" class=\"nounderline abstract_t\">Marx C, Bornstein SR, Wolkersd&ouml;rfer GW, et al. Relevance of major histocompatibility complex class II expression as a hallmark for the cellular differentiation in the human adrenal cortex. J Clin Endocrinol Metab 1997; 82:3136.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/51\" class=\"nounderline abstract_t\">Simpson ER, Waterman MR. Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH. Annu Rev Physiol 1988; 50:427.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/52\" class=\"nounderline abstract_t\">Clark BJ, Ranganathan V, Combs R. Steroidogenic acute regulatory protein expression is dependent upon post-translational effects of cAMP-dependent protein kinase A. Mol Cell Endocrinol 2001; 173:183.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/53\" class=\"nounderline abstract_t\">Manna PR, Stetson CL, Slominski AT, Pruitt K. Role of the steroidogenic acute regulatory protein in health and disease. Endocrine 2016; 51:7.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/54\" class=\"nounderline abstract_t\">Clark BJ. ACTH Action on StAR Biology. Front Neurosci 2016; 10:547.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/55\" class=\"nounderline abstract_t\">Kramer RE, Simpson ER, Waterman MR. Induction of 11 beta-hydroxylase by corticotropin in primary cultures of bovine adrenocortical cells. J Biol Chem 1983; 258:3000.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/56\" class=\"nounderline abstract_t\">Kramer RE, Anderson CM, Peterson JA, et al. Adrenodoxin biosynthesis by bovine adrenal cells in monolayer culture. Induction by adrenocorticotropin. J Biol Chem 1982; 257:14921.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/57\" class=\"nounderline abstract_t\">Plump AS, Erickson SK, Weng W, et al. Apolipoprotein A-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid production. J Clin Invest 1996; 97:2660.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/58\" class=\"nounderline abstract_t\">Trzeciak WH, Simpson ER, Scallen TJ, et al. Studies on the synthesis of sterol carrier protein-2 in rat adrenocortical cells in monolayer culture. Regulation by ACTH and dibutyryl cyclic 3',5'-AMP. J Biol Chem 1987; 262:3713.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/59\" class=\"nounderline abstract_t\">Umakoshi H, Xiaomei Y, Ichijo T, et al. Reassessment of the cosyntropin stimulation test in the confirmatory diagnosis and subtype classification of primary aldosteronism. Clin Endocrinol (Oxf) 2017; 86:170.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/60\" class=\"nounderline abstract_t\">Raff H, Sharma ST, Nieman LK. Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia. Compr Physiol 2014; 4:739.</a></li><li><a href=\"https://www.uptodate.com/contents/adrenal-steroid-biosynthesis/abstract/61\" class=\"nounderline abstract_t\">Steichen O, Amar L. Diagnostic criteria for adrenal venous sampling. Curr Opin Endocrinol Diabetes Obes 2016; 23:218.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 120 Version 16.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H239059600\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">MECHANISM OF ACTH ACTION</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">CHOLESTEROL SUBSTRATE</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">CORTISOL BIOSYNTHESIS</a><ul><li><a href=\"#H5\" id=\"outline-link-H5\">Pregnenolone synthesis by CYP11A1</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">Conversion of pregnenolone to progesterone</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">Progesterone to 17-alpha-hydroxyprogesterone</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">17-alpha-hydroxyprogesterone to 11-deoxycortisol</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">Conversion of 11-deoxycortisol to cortisol</a></li></ul></li><li><a href=\"#H10\" id=\"outline-link-H10\">ALDOSTERONE BIOSYNTHESIS</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">ADRENAL ANDROGEN BIOSYNTHESIS</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">ACUTE AND CHRONIC ACTIONS OF ACTH</a></li><li><a href=\"#H239059580\" id=\"outline-link-H239059580\">METABOLISM OF ADRENAL STEROIDS</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">OVERVIEW OF CAH</a></li><li><a href=\"#H239059600\" id=\"outline-link-H239059600\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ENDO/120|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=ENDO/71558\" class=\"graphic graphic_figure\">- Normal adrenal steroidogenesis</a></li></ul></li><li><div id=\"ENDO/120|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ENDO/55287\" class=\"graphic graphic_table\">- Steroidogenic enzymes</a></li><li><a href=\"image.htm?imageKey=ENDO/76865\" class=\"graphic graphic_table\">- Different forms of CAH</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=adrenal-hyperandrogenism\" class=\"medical medical_review\">Adrenal hyperandrogenism</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=causes-and-clinical-manifestations-of-primary-adrenal-insufficiency-in-children\" class=\"medical medical_review\">Causes and clinical manifestations of primary adrenal insufficiency in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency-in-infants-and-children\" class=\"medical medical_review\">Diagnosis of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in infants and children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-primary-aldosteronism\" class=\"medical medical_review\">Diagnosis of primary aldosteronism</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=etiology-diagnosis-and-treatment-of-hypoaldosteronism-type-4-rta\" class=\"medical medical_review\">Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=familial-hyperaldosteronism\" class=\"medical medical_review\">Familial hyperaldosteronism</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency\" class=\"medical medical_review\">Genetics and clinical presentation of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=inborn-errors-of-metabolism-epidemiology-pathogenesis-and-clinical-features\" class=\"medical medical_review\">Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=medical-therapy-of-hypercortisolism-cushings-syndrome\" class=\"medical medical_review\">Medical therapy of hypercortisolism (Cushing's syndrome)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=metabolism-of-adrenal-steroids\" class=\"medical medical_review\">Metabolism of adrenal steroids</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=uncommon-congenital-adrenal-hyperplasias\" class=\"medical medical_review\">Uncommon congenital adrenal hyperplasias</a></li></ul></div></div>","javascript":null}